IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,334,097 | -15.9% | 273,100 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $5,153,397 | +374.0% | 273,100 | -3.5% | 0.00% | +300.0% |
| Q1 2023 | $1,087,104 | -68.7% | 283,100 | -59.6% | 0.00% | -66.7% |
| Q4 2022 | $3,473,126 | -0.2% | 700,227 | -3.9% | 0.00% | 0.0% |
| Q3 2022 | $3,481,000 | +6.2% | 728,327 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,277,000 | -9.0% | 728,327 | -3.8% | 0.00% | 0.0% |
| Q1 2022 | $3,602,000 | -36.3% | 756,827 | -0.6% | 0.00% | -25.0% |
| Q4 2021 | $5,652,000 | +26.4% | 761,727 | -3.4% | 0.00% | +33.3% |
| Q3 2021 | $4,473,000 | -15.6% | 788,927 | -1.9% | 0.00% | -25.0% |
| Q2 2021 | $5,297,000 | -22.7% | 803,827 | -5.0% | 0.00% | -20.0% |
| Q1 2021 | $6,854,000 | +18.0% | 846,127 | -6.1% | 0.01% | +25.0% |
| Q4 2020 | $5,810,000 | +79.2% | 900,827 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $3,243,000 | -25.2% | 900,827 | -4.5% | 0.00% | -25.0% |
| Q2 2020 | $4,338,000 | +27.4% | 943,127 | -5.5% | 0.00% | +33.3% |
| Q1 2020 | $3,404,000 | -81.9% | 998,127 | -72.8% | 0.00% | -78.6% |
| Q4 2019 | $18,761,000 | +109.9% | 3,674,927 | -0.5% | 0.01% | +100.0% |
| Q3 2019 | $8,939,000 | +9.6% | 3,693,800 | -1.7% | 0.01% | +16.7% |
| Q2 2019 | $8,154,000 | -19.9% | 3,757,600 | 0.0% | 0.01% | -14.3% |
| Q1 2019 | $10,183,000 | -43.7% | 3,757,600 | -0.2% | 0.01% | -53.3% |
| Q4 2018 | $18,072,000 | -49.6% | 3,765,000 | -0.6% | 0.02% | -37.5% |
| Q3 2018 | $35,880,000 | -3.6% | 3,788,800 | -0.9% | 0.02% | -14.3% |
| Q2 2018 | $37,201,000 | -7.5% | 3,823,300 | 0.0% | 0.03% | -6.7% |
| Q1 2018 | $40,221,000 | +64.1% | 3,823,300 | 0.0% | 0.03% | +57.9% |
| Q4 2017 | $24,507,000 | -16.2% | 3,823,300 | 0.0% | 0.02% | -20.8% |
| Q3 2017 | $29,248,000 | +6.0% | 3,823,300 | -1.5% | 0.02% | 0.0% |
| Q2 2017 | $27,605,000 | +79.9% | 3,882,500 | -2.1% | 0.02% | +71.4% |
| Q1 2017 | $15,348,000 | +48.9% | 3,966,000 | -21.5% | 0.01% | +40.0% |
| Q4 2016 | $10,308,000 | -60.0% | 5,052,943 | -47.5% | 0.01% | -61.5% |
| Q3 2016 | $25,779,000 | -17.2% | 9,619,122 | -4.9% | 0.03% | -21.2% |
| Q2 2016 | $31,150,000 | -71.6% | 10,113,629 | -21.4% | 0.03% | -71.1% |
| Q1 2016 | $109,631,000 | -37.2% | 12,867,483 | 0.0% | 0.11% | -36.3% |
| Q4 2015 | $174,612,000 | +41.4% | 12,867,483 | 0.0% | 0.18% | +30.7% |
| Q3 2015 | $123,528,000 | -33.2% | 12,867,483 | 0.0% | 0.14% | -24.7% |
| Q2 2015 | $185,034,000 | +64.0% | 12,867,483 | +2.0% | 0.18% | +65.5% |
| Q1 2015 | $112,852,000 | +52.6% | 12,609,150 | +4.0% | 0.11% | +46.7% |
| Q4 2014 | $73,975,000 | -41.4% | 12,127,073 | +1.8% | 0.08% | -44.4% |
| Q3 2014 | $126,216,000 | -10.7% | 11,918,396 | -0.0% | 0.14% | -12.9% |
| Q2 2014 | $141,280,000 | -25.3% | 11,922,396 | -5.9% | 0.16% | -27.6% |
| Q1 2014 | $189,244,000 | +1.8% | 12,675,427 | 0.0% | 0.21% | -4.0% |
| Q4 2013 | $185,949,000 | -13.3% | 12,675,427 | +0.6% | 0.22% | -20.9% |
| Q3 2013 | $214,481,000 | +3.4% | 12,601,727 | +0.8% | 0.28% | -5.1% |
| Q2 2013 | $207,498,000 | – | 12,507,427 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |